Other
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: > Immunological products, put up in measured doses or in forms or packings for retail sale > Other
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3002.15.00.91
Monoclonal Antibody Infusion Kit for Rheumatoid Arthritis
This kit contains rituximab, a monoclonal antibody, pre-filled in measured-dose syringes for intravenous infusion to treat rheumatoid arthritis. It qualifies under HTS 3002.15.00.91 as an immunological product (peptide/protein regulating immunological processes) put up in measured doses for retail sale. Biotechnologically produced and modified for therapeutic use.
Interferon Beta-1a Injection for Multiple Sclerosis
Prefilled syringes of recombinant interferon beta-1a, an immunological protein for modulating immune response in MS patients, packaged in retail-ready measured doses. Falls under HTS 3002.15.00.91 per chapter notes defining immunological products as proteins like interferons in retail forms.
Adalimumab Prefilled Syringe for Psoriasis Treatment
Humira-brand adalimumab, a TNF inhibitor monoclonal antibody in 40mg prefilled syringes for retail sale, used prophylactically against autoimmune psoriasis flares. Classified in HTS 3002.15.00.91 as a biotechnological immunological product in measured retail doses.
Interleukin-2 Injection for Melanoma Therapy
Recombinant human IL-2 in single-dose vials for retail, an immunological cytokine stimulating T-cell response in cancer immunotherapy. HTS 3002.15.00.91 applies as it matches chapter note for interleukins as immunological products in measured retail packs.
Bevacizumab Biosimilar Vial for Oncology
Avastin biosimilar bevacizumab, a VEGF monoclonal antibody in 100mg/4ml vials for retail infusion in cancer treatment, modulating angiogenesis via immune regulation. Fits HTS 3002.15.00.91 for MAB immunological products in measured doses.
Denosumab Injection for Osteoporosis
Prolia-brand denosumab, RANKL inhibitor antibody in 60mg prefilled syringes for retail, preventing bone resorption through immunological modulation. HTS 3002.15.00.91 for antibody-based immunological products in retail measured forms.